53 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
and operations could suffer in the event of an actual or perceived information security incident such as a cybersecurity breach, system failure, or other … or perceived information security incident such as a cybersecurity breach, system failure, or other compromise of our systems or those of a third-party
8-K
EX-1.1
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Entry into a Material Definitive Agreement
4:15pm
in connection therewith (the “Sarbanes-Oxley Act”), including Section 402 related to loans and Sections 302 and 906 related to certifications.
(vv)Cybersecurity
424B5
XENE
Xenon Pharmaceuticals Inc
29 Nov 23
Prospectus supplement for primary offering
5:05pm
business and operations could suffer in the event of an actual or perceived information security incident such as a cybersecurity breach, system failure … and operations could suffer in the event of an actual or perceived information security incident such as a cybersecurity breach, system failure, or other
424B5
4xliah9rc4a7pj
23 Jun 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-1.1
mjbc50rt
23 Jun 22
Other Events
4:04pm
424B5
eh8faz282d
22 Jun 22
Prospectus supplement for primary offering
4:05pm
424B5
uetn0
1 Mar 22
Prospectus supplement for primary offering
5:12pm
424B5
1vb5lx5
6 Oct 21
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
m3agvd7kund y0
6 Oct 21
Other Events
4:50pm